Population Diagnostics, Inc.

Website Links

Description

Mr. Chinitz co-founded Population Diagnostics in 2006 and has over 20 years experience globally introducing new and leading edge technology to the research, pharmaceutical and diagnostic communities. He has held various positions on pioneering commercial teams within the life science industry leaders Hoffmann-La Roche, Applied Biosystems (acquired by Invitrogen), Affymetrix, Third Wave Technologies (acquired by Hologic) and Enzo Life Sciences, including director and executive management level positions. He has broad-based expertise in sales, marketing, and business development and was intimately involved with the pioneering product launches of DNA sequencing, PCR, gene expression and genotyping technologies that were integral tools adopted for the Human Genome Project and today are the mainstream tools and methods used for human disease research. His role in the worldwide market adoption of microarrays has inspired Mr. Chinitz ’s vision for the acceleration of genetic discoveries and their clinical translation into simple predictive tests used by physicians to deliver personalized medicine to their patients. Mr. Chinitz ’s BS degree is in Biochemical Pharmacology from SUNY Buffalo ’s School of Pharmacy, he attended business school through the UC Berkeley extension and he currently serves on the board of the Cold Spring Harbor Laboratory DNA Learning Center. Eli Hatchwell, MD PhD, Founder & Chief Scientific Officer Dr. Hatchwell co-founded Population Diagnostics in 2006 and has been engaged in genetic research for over 16 years including as an investigator at Cold Spring Harbor Laboratory and in his current academic appointment as an Associate Professor and Director of the Genomics Core Facility at Stony Brook University, SUNY. Dr. Hatchwell ’s clinical and technical expertise in investigating human genetic disorders led him to recognize early on that human genetic diversity was grossly underestimated, there was a critical need to comprehensively understand the vast spectrum of normal genetic variation in the population and that rare variants are largely responsible for causing common disease – the underlying principles of the genetic biomarker discovery technology of Population Diagnostics. His current academic research focus is to uncover the spectrum of genetic variation in disease, including the identification of causative genes in autism and congenital heart disease. He is recognized as a key collaborator in the development of one of the first genome-wide BAC-based comparative genomic hybridization (CGH) microarray platforms and remains at the forefront of cytogenetic and genome analysis through early adoption of leading edge technologies. Dr. Hatchwell collaborates with human genetics researchers worldwide, is a coauthor on numerous peer-reviewed articles, encompassing both clinical genetics and genome technologies, and is senior editor of a book series aimed at educating medical specialists on genetic principles and practices. He is also a certified Medical Geneticist (UK) with many years of experience in clinical practice. Dr.

Products & services

Similar companies nearby